What factors affect the sufficient dose of phentermin?
PHENTERMINE is a medicine that is part of the amphetamine class of drugs and is used for a short time to support weight loss. The main factor affecting the correct dosing of phentermine for the patient is the age, because the doses used for the weight loss of adults and pediatric weight usually differ completely. Other variables may affect the dosage used for the patient, such as whether this medicine is administered in the form of a capsule or tablet. Friendly health conditions that affect kidney or liver function, or kidney or liver function may also affect the dose prescribed to the patient. There are also tablets with prolonged release and resin phentermin, which require only one dose a day. PHENTERMINE DOSAGE for these wording usually consists of 15 mg to 37.5 mg when waking up. Due to the ability of this drug to cause insomnia, the formulation should not be taken more than 10 to 14 hours before bedtime.
Children can also take this weight loss medicine and can be administered up to 8 mg capsules with immediate release half an hour before meals three times a day. Phentermine dosing for prolonged release preparations, such as tablets or resins, are usually 15 mg or 18.75 mg, with the morning awakening. Up to 37.5 mg of prolonged release formulation can be adopted by children, but the dosage is more rare in this population due to the risk of increased side effects.
Some health conditions, especially those that affect the liver or kidneys, can increase the effects of phentermin. The liver and kidneys are responsible for breaking and excretion many types of drugs, including phentermin. Therefore, the damage or endangered functioning of both organ systems can extend how long the standard dose of phentermine is active in the affected individual.
For this reason, some doctors may inform that if this medicine is to be prescribed to individuals with LE damageDvin or liver, the dose of phentermin should be reduced. Reducing the dose of this drug can help reduce side effects from the accumulation of this drug in the bloodstream. Usually, a dose of 18.75 mg of prolonged release formulation is used, as the dose reduction with immediate release is not possible with the level of dosage in which the formulation with immediate release is produced.